SCHEMBL3896643

SCHEMBL3896643

CCOC(=O)c1c(N)n(C)c2cc(Cl)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
ALOX15 P16050 5/20 0.51
HPGD P15428 4/20 0.51
KDM4E B2RXH2 3/20 0.51
TSHR P16473 2/20 0.51
HSD17B10 Q99714 2/20 0.51
CASP1 P29466 1/20 0.51
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
LMNA P02545 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1924840 0.80 ENPP2 (0.45) ALDH1A1ALOX15TSHRHSD17B10CYP1A2
SCHEMBL9392477 0.80 ALDH1A1 (0.69) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL3923885 0.79 ALOX15 (0.47) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL5702463 0.79 ALOX15 (0.47) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL30691954 0.76 ADORA2A (0.48) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL17959424 0.76 ALOX15 (0.47) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL26631744 0.76 ADORA2A (0.48) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL17974081 0.75 ALOX15 (0.44) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL30881955 0.75 ALOX15 (0.54) ALDH1A1ALOX15HPGDKDM4ETSHR
SCHEMBL16376991 0.73 ALOX15 (0.51) ALDH1A1ALOX15HPGDKDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215741-A1 1H-Pyrimido[4,5-b]indole Derivatives, Their Preparation and Therapeutic Use SANOFI-AVENTIS (FR) 2009-08-27 US disclosed
US-7547706-B2 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use SANOFI-AVENTIS (FR) 2009-06-16 US disclosed
US-20080125410-A1 7-chloro-N,N-9-trimethyl-2-(6-methylpyridin-3-yl)-9H-pyrimido[4,5-b]indole-4-carboxamide; ethyl 7-chloro-9-methyl-2-phenyl-9H-pyrimido[4,5-b]indole-4-carboxylate; 4-[(4-azetidin-1-yl)piperidin-1-ylcarbonyl]-7-chloro-9-methyl-2-phenyl-9H-pyrimido-[4,5-b]indole; Alzheimer's or Parkinson's disease SANOFI-AVENTIS (FR) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215741-A1 1H-Pyrimido[4,5-b]indole Derivatives, Their Preparation and Therapeutic Use IDO1, IDO2, TPH1 ALDH1A1 107/4885ALOX15 963/4885HPGD 483/4885
US-20080125410-A1 7-chloro-N,N-9-trimethyl-2-(6-methylpyridin-3-yl)-9H-pyrimido[4,5-b]indole-4-carboxamide; ethyl 7-chloro-9-methyl-2-phenyl-9H-pyrimido[4,5-b]indole-4-carboxylate; 4-[(4-azetidin-1-yl)piperidin-1-ylcarbonyl]-7-chloro-9-methyl-2-phenyl-9H-pyrimido-[4,5-b]indole; Alzheimer's or Parkinson's disease PARK7, SNCA, PSEN2 ALDH1A1 777/4885ALOX15 3102/4885HPGD 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.